Asia Risk technology rankings – VOTE NOW!

ar-technology-2013

Voting is now open for Asia Risk's 8th annual technology survey

Asia Risk is compiling its annual technology rankings – and we need YOUR help!

If you are a bank, broker, pension fund, insurer, asset manager or a hedge fund user of financial risk management and derivatives service technology, please take a few minutes to vote in our survey. This gives YOU a chance to highlight the top derivatives dealers in Asia.

PLEASE CLICK HERE TO VOTE IN THE SURVEY.

Once you have completed the survey, you will be eligible for a FREE copy of the September issue of Asia Risk magazine, which will contain the full results and analysis of the rankings.

All votes will be treated in the strictest confidence, in accordance with the full terms of the survey.

Thank you for taking the time to participate in this important survey of Asia's derivatives market.

IMPORTANT: When aggregating the results, we look to strip out what we consider to be invalid votes. These include people voting for their own firm, multiple votes from the same person or IP address, votes from people using non-business accounts, votes by people who choose the same firm indiscriminately throughout the poll, votes by people who are clearly not active in a particular area, and block votes from groups of people in the same institution voting for the same firm. For instance, we do not allow block votes from 20 people on the same desk, in the same location, all voting in exactly the same way, within hours and in some cases minutes of each other. We see this as a clear attempt to unfairly manipulate the poll. The editor's decision is final.

Aaron Woolner

Editor, Asia Risk

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here